Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.78
+0.53 (4.00%)
Aug 13, 2025, 4:00 PM - Market closed

Company Description

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies.

Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient.

It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California.

Carlsmed, Inc.
Carlsmed logo
Country United States
Founded 2018
IPO Date Jul 23, 2025
Industry Medical Devices
Sector Healthcare
Employees 89
CEO Michael Cordonnier

Contact Details

Address:
1800 Aston Avenue, Suite 100
Carlsbad, California 92008
United States
Phone 760 766 1923
Website carlsmed.com

Stock Details

Ticker Symbol CARL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $15.00
CIK Code 0001794546
Employer ID 83-1081863
SIC Code 3841

Key Executives

Name Position
Michael (Mike) Cordonnier Chairman, Chief Executive Officer, President, and Co-Founder
Leonard (Leo) Greenstein Chief Financial Officer, Treasurer
William (Scott) Durall Chief Commercial Officer
Niall Casey Co-Founder, Chief Intellectual Property Officer, Secretary, Director
Jonathan (Jon) Root, M.D. Director
Robert Mittendorff, M.D. Director
Philip (Phil) Young Director
Kevin Sidow Director
Kevin O’Boyle Director

Latest SEC Filings

Date Type Title
Jul 24, 2025 SCHEDULE 13G Filing
Jul 24, 2025 8-K Current Report
Jul 24, 2025 S-8 Securities to be offered to employees in employee benefit plans
Jul 24, 2025 424B4 Prospectus
Jul 22, 2025 EFFECT Notice of Effectiveness
Jul 22, 2025 CERT Certification by an exchange approving securities for listing
Jul 21, 2025 8-A12B Registration of securities
Jul 15, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jun 26, 2025 S-1 General form for registration of securities under the Securities Act of 1933
May 30, 2025 DRS/A [Amend] [Cover] Draft Registration Statement